BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 8882031)

  • 41. [A case of systemic lupus erythematosus (SLE) with a neurogenic bladder, successful treatment with intravenous cyclophosphamide pulse therapy].
    Nakagawa M; Nishinarita M
    Ryumachi; 1999 Oct; 39(5):763-7. PubMed ID: 10614171
    [TBL] [Abstract][Full Text] [Related]  

  • 42. B-cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients.
    Leandro MJ; Cambridge G; Edwards JC; Ehrenstein MR; Isenberg DA
    Rheumatology (Oxford); 2005 Dec; 44(12):1542-5. PubMed ID: 16188950
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acute transverse myelopathy in systemic lupus erythematosus: clinical presentation, treatment, and outcome.
    Mok CC; Lau CS; Chan EY; Wong RW
    J Rheumatol; 1998 Mar; 25(3):467-73. PubMed ID: 9517765
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oral bolus cyclophosphamide--liberating libation or nauseating nostrum?
    McCune WJ
    J Rheumatol; 1996 Feb; 23(2):212-3. PubMed ID: 8882020
    [No Abstract]   [Full Text] [Related]  

  • 45. Is aggressive therapy effective for lupus?
    Klippel JH
    Rheum Dis Clin North Am; 1993 Feb; 19(1):249-61. PubMed ID: 8356258
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The long-term parenteral use of cyclophosphane in treating patients with systemic lupus erythematosus and central nervous system involvement].
    Ivanova MM; Bliziuk OI; Travkina IV
    Ter Arkh; 1995; 67(5):45-7. PubMed ID: 7638778
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Primary pulmonary hypertension in a patient with systemic lupus erythematosus: partial improvement with cyclophosphamide.
    Groen H; Bootsma H; Postma DS; Kallenberg CG
    J Rheumatol; 1993 Jun; 20(6):1055-7. PubMed ID: 8350313
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chronic inflammatory polyneuropathy complicating SLE: successful treatment with monthly oral pulse cyclophosphamide.
    Sigal LH
    J Rheumatol; 1989 Nov; 16(11):1518-9. PubMed ID: 2600956
    [No Abstract]   [Full Text] [Related]  

  • 49. Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial.
    Gourley MF; Austin HA; Scott D; Yarboro CH; Vaughan EM; Muir J; Boumpas DT; Klippel JH; Balow JE; Steinberg AD
    Ann Intern Med; 1996 Oct; 125(7):549-57. PubMed ID: 8815753
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intravenous cyclophosphamide therapy of severe SLE.
    McCune WJ; Fox D
    Rheum Dis Clin North Am; 1989 Aug; 15(3):455-77. PubMed ID: 2672132
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Treatment of systemic lupus erythematosis with high doses of cyclophosphamide].
    Baranowska-Daca E
    Wiad Lek; 1993 Nov; 46(21-22):868-71. PubMed ID: 7817583
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Cyclophosphamide therapy in systemic lupus erythematosus].
    Backhaus M; Hiepe F
    Z Rheumatol; 1997; 56(4):178-89. PubMed ID: 9417758
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Systemic manifestations of systemic lupus erythematosus.
    Jagadish TK; Kasthuri AS; Uberoi HS; Chopra A; Gupta MM; Dham SK; Bhalla IP; Kumaravelu S; Bhangui GR
    J Assoc Physicians India; 1990 May; 38(5):329-32. PubMed ID: 2387812
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pulse cyclophosphamide in the treatment of neuropsychiatric systemic lupus erythematosus.
    Ramos PC; Mendez MJ; Ames PR; Khamashta MA; Hughes GR
    Clin Exp Rheumatol; 1996; 14(3):295-9. PubMed ID: 8809444
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intermittent cyclophosphamide for the treatment of autoimmune thrombocytopenia in systemic lupus erythematosus.
    Boumpas DT; Barez S; Klippel JH; Balow JE
    Ann Intern Med; 1990 May; 112(9):674-7. PubMed ID: 2334081
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [A study on interval of intravenous cyclophosphamide pulse in the treatment of severe systemic lupus erythematosus].
    Yang X; Yin P; Gao X
    Zhonghua Nei Ke Za Zhi; 1996 Apr; 35(4):257-60. PubMed ID: 9387643
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Levamisole in systemic lupus erythematosus.
    Ogawa K; Sano T; Hisano G; Tsubura E
    Ann Allergy; 1979 Sep; 43(3):187-9. PubMed ID: 314248
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy.
    Boumpas DT; Austin HA; Vaughan EM; Yarboro CH; Klippel JH; Balow JE
    Ann Intern Med; 1993 Sep; 119(5):366-9. PubMed ID: 8338289
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Monthly intravenous cyclophosphamide in the treatment of severe systemic lupus erythematosus.
    Sessoms SL; Kovarsky J
    Clin Exp Rheumatol; 1984; 2(3):247-51. PubMed ID: 6529878
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Cyclophosphamide pulse therapy of systemic lupus erythematosus with renal involvement].
    Hein R; Neumann KH; Koch KM; Deicher H; Schmidt RE
    Immun Infekt; 1991 Apr; 19(2):57-8. PubMed ID: 1855811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.